Terms: = Head and neck cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Treatment
18 results:
1. Efficacy and safety of anlotinib-based chemotherapy for locally advanced or metastatic anaplastic thyroid carcinoma.
Zheng X; Wang J; Ye T; Tang W; Pan X; Wang S; Liu J
Endocrine; 2023 Sep; 81(3):540-546. PubMed ID: 37219702
[TBL] [Abstract] [Full Text] [Related]
2. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
Boilève A; Faron M; Fodil-Cherif S; Bayle A; Lamartina L; Planchard D; Tselikas L; Kanaan C; Scoazec JY; Ducreux M; Italiano A; Baudin E; Hadoux J
Eur J Cancer; 2023 Jun; 186():122-132. PubMed ID: 37062210
[TBL] [Abstract] [Full Text] [Related]
3. Deep learning assisted contrast-enhanced CT-based diagnosis of cervical lymph node metastasis of oral cancer: a retrospective study of 1466 cases.
Xu X; Xi L; Wei L; Wu L; Xu Y; Liu B; Li B; Liu K; Hou G; Lin H; Shao Z; Su K; Shang Z
Eur Radiol; 2023 Jun; 33(6):4303-4312. PubMed ID: 36576543
[TBL] [Abstract] [Full Text] [Related]
4. Pulmonary lymphangioleiomyomatosis and renal angiomyolipoma in a patient with systemic lupus erythematosus: A case report.
Koh JS; Oh S; Chung C
Medicine (Baltimore); 2022 Sep; 101(38):e30554. PubMed ID: 36197220
[TBL] [Abstract] [Full Text] [Related]
5. Germline genetic biomarkers to stratify patients for personalized radiation treatment.
Deichaite I; Hopper A; Krockenberger L; Sears TJ; Sutton L; Ray X; Sharabi A; Navon A; Sanghvi P; Carter H; Moiseenko V
J Transl Med; 2022 Aug; 20(1):360. PubMed ID: 35962345
[TBL] [Abstract] [Full Text] [Related]
6. CIB2 regulates mTORC1 signaling and is essential for autophagy and visual function.
Sethna S; Scott PA; Giese APJ; Duncan T; Jian X; Riazuddin S; Randazzo PA; Redmond TM; Bernstein SL; Riazuddin S; Ahmed ZM
Nat Commun; 2021 Jun; 12(1):3906. PubMed ID: 34162842
[TBL] [Abstract] [Full Text] [Related]
7. Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2.
Kirk CW; Donnelly DE; Hardy R; Shepherd CW; Morrison PJ
Ulster Med J; 2020 Jan; 89(1):14-16. PubMed ID: 32218621
[TBL] [Abstract] [Full Text] [Related]
8. Profiles of genomic alterations in primary esophageal follicular dendritic cell sarcoma: A case report.
Ren W; Sun Q; Wu PY; Huang B; Yang J; Yan J; Liu BR
Medicine (Baltimore); 2018 Nov; 97(48):e13413. PubMed ID: 30508944
[TBL] [Abstract] [Full Text] [Related]
9. Tuberous Sclerosis Complex in 29 Children: Clinical and Genetic Analysis and Facial Angiofibroma Responses to Topical Sirolimus.
Wang S; Liu Y; Wei J; Zhang J; Wang Z; Xu Z
Pediatr Dermatol; 2017 Sep; 34(5):572-577. PubMed ID: 28771801
[TBL] [Abstract] [Full Text] [Related]
10. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.
Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B
Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290
[TBL] [Abstract] [Full Text] [Related]
11. Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway.
Han B; Cui H; Kang L; Zhang X; Jin Z; Lu L; Fan Z
Tumour Biol; 2015 Aug; 36(8):6295-304. PubMed ID: 25854169
[TBL] [Abstract] [Full Text] [Related]
12. Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements.
Teng JM; Cowen EW; Wataya-Kaneda M; Gosnell ES; Witman PM; Hebert AA; Mlynarczyk G; Soltani K; Darling TN
JAMA Dermatol; 2014 Oct; 150(10):1095-101. PubMed ID: 25029267
[TBL] [Abstract] [Full Text] [Related]
13. Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response.
Truchuelo T; Díaz-Ley B; Ríos L; Alcántara J; Jaén P
Dermatol Online J; 2012 Jan; 18(1):15. PubMed ID: 22301052
[TBL] [Abstract] [Full Text] [Related]
14. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.
Wataya-Kaneda M; Tanaka M; Nakamura A; Matsumoto S; Katayama I
Br J Dermatol; 2011 Oct; 165(4):912-6. PubMed ID: 21692771
[TBL] [Abstract] [Full Text] [Related]
15. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
[TBL] [Abstract] [Full Text] [Related]
16. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract] [Full Text] [Related]
17. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
[TBL] [Abstract] [Full Text] [Related]
18. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
[TBL] [Abstract] [Full Text] [Related]
